Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score

Clinica Chimica Acta

Volumn 382, Issue 1-2, 2007, Pages 106-111

  Kuklinska, Agnieszka M ^a   Sobkowicz, Bozena ^a   Mroczko, Barbara ^a   Sawicki, Robert ^a   Musial, Wlodzimierz J ^a   Knapp, Malgorzata ^a   Dobrzycki, Slawomir ^a   Szmitkowski, Maciej ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

BNP; CRP; STEMI; TRS

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; IMMUNOASSAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME VARIABLE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION; TURBIDIMETRY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ARRHYTHMIA; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 34249047954     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.04.002     Document Type: Article

References (18)

1. Scirica B.M., and Morrow D.A. Troponins in acute coronary syndromes. Semin Vasc Med 3 (2003) 363-374
2. Morrow D.A., Rifai N., Antman E.M., et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin I in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol 31 (1998) 1460-1465
3. de Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
4. Morrow D.A., de Lemos J.A., Sabatine M.S., et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction. B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol 41 (2003) 1264-1272
5. Galvani M., Ferrini D., and Ottani F. Natriuretic peptides for risk stratification of patients with acute coronary syndromes. Eur J Heart Fail 6 (2004) 327-333
6. Morrow D.A., Antman E.M., Murphy S.A., et al. The risk score profile: a novel approach to characterizing the risk of populations enrolled in clinical studies. Eur Heart J 25 (2004) 1139-1145
7. Ilkhanoff L., O'Donnell C.J., Camargo C.A., O'Halloran T.D., Giugliano R.P., and Lloyd-Jones D.M. Usefulness of the TIMI Risk Index in predicting short- and long-term mortality in patients with acute coronary syndromes. Am J Cardiol 96 (2005) 773-777
8. de Lemos J.A., McGuire D.K., and Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 362 (2003) 316-322
9. Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Elevation of B-type natriuretic peptide in the setting of myocardial ischemia. Circulation 104 Suppl. II (2001) 485 [Abstract]
10. Morita E., Yasue H., Yoshimura M., et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88 (1993) 82-91
11. Richards A.M., Nicholls M.G., Yandle T.G., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 97 (1998) 1921-1929
12. Talwar S., Squire I.B., Downie P.F., et al. Profile of plasma N-terminal proBNP following acute myocardial infarction. Correlation with left ventricular systolic dysfunction. Eur Heart J 21 (2000) 1514-1521
13. Mega J.L., Morrow D.A., de Lemos J.A., et al. B-type natriuretic peptide at presentation and prognosis in patients with ST-elevation myocardial infarction. An ENTIRE-TIMI-23 Substudy. J Am Coll Cardiol 44 (2004) 335-339
14. Pepys M.B. C-reactive protein fifty years on. Lancet 1 (1981) 653-656
15. Libby P., and Ridker P.M. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med 116 6A (2004) 9S-16S
16. Anzai T., Yoshikawa T., Shiraki H., et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 96 (1997) 778-784
17. Morrow D.A., Antman E.M., Parsons L., et al. Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3. JAMA 286 (2001) 1356-1359
18. Kirk V., Bay M., Parner J., et al. N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF). Eur J Heart Fail 6 (2004) 335-341